疾病預測分析市場規模、佔有率和成長分析：按組件、部署模式、最終用戶、應用領域和地區分類－2026-2033年產業預測

2024 年全球疾病預測分析市場價值為 26 億美元，預計到 2033 年將從 2025 年的 32.4 億美元成長到 189.6 億美元，預測期（2026-2033 年）的複合年成長率為 24.7%。

全球疾病預測分析市場的主要驅動力是醫療保健數據的加速數位化以及機器學習技術的進步，這些技術能夠將原始數據轉化為可執行的見解。該市場涵蓋軟體、平台和服務，這些軟體、平台和服務整合了臨床、基因組和社會決定因素數據，用於預測疾病的發生、發展和集體爆發，最終改善健康結果並降低成本。隨著醫療保健模式向價值導向轉變，能夠識別高風險患者以進行高效資源分配的預測工具變得至關重要。此外，人工智慧透過使系統能夠從各種臨床訊號中學習，促進早期檢測和個人化風險分層，從而推動了市場成長。實際應用範圍廣泛，從利用穿戴式裝置進行慢性病管理到醫院環境中的預測演算法，為整合平台和以結果為導向的合約供應商創造了眾多機會。

全球疾病預測分析市場促進因素

全球疾病預測分析市場正受到機器學習技術進步的顯著推動。這些技術徹底革新了從各種臨床和流行病學數據中識別複雜模式的方式。這些改進提高了演算法的敏感度和適應性，從而能夠進行精準的風險評估、快速識別疫情指標，並針對不同人群進行個人化預測。這項進展增強了醫療服務提供者和公共衛生組織的信心，並推動了這些創新解決方案的普及應用。隨著人們對預測模型有效性的信心不斷增強，對其部署和整合的投資也在增加，進一步促進了市場成長和新服務的湧現。

全球疾病預測分析市場中的限制因素

全球疾病預測分析市場面臨著資料隱私和安全的諸多限制。這些問題會帶來法律和聲譽風險，各機構必須在部署前加以解決。這些顧慮導致採購流程延長，部署策略也趨於謹慎。遵守各種法規結構以及實施健全的資料管治進一步增加了營運成本，使得一些機構在共用關鍵資料集方面猶豫不決。這種限制因素限制了模型訓練和跨機構檢驗的有效性。因此，這些挑戰阻礙了預測分析在臨床工作流程中的整合，並減緩了市場上全面且可互通解決方案的整體普及。

全球疾病預測分析市場趨勢

全球疾病預測分析市場正經歷著向基因組主導預測模型的顯著轉變，這主要得益於基因組分析技術的進步，使得整合遺傳風險標記和體學表現型成為可能。這項創新實現了個人化的風險分層和預防策略，最佳化了臨床工作流程和多組學分析，從而改善了患者管理。對可解釋輸出和可互通模型的需求，以及負責任的管治實踐，正在推動醫療保健系統對這些技術的廣泛應用。此外，實驗室、資訊科技供應商和醫療保健提供者之間的策略夥伴關係，能夠有效地將分子層面的洞察轉化為可操作的指導，最終在不同的醫療保健環境中促進永續的公共衛生成果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球疾病預測分析市場規模：按組件分類

• 軟體
• 服務

全球疾病預測分析市場規模：依部署模式分類

• 基於雲端的
• 現場

全球疾病預測分析市場規模：依最終用戶分類

• 付款人
• 提供者
• 其他

全球疾病預測分析市場規模：按應用領域分類

• 腫瘤學
• 心血管疾病
• 感染疾病
• 個人化治療方案

全球疾病預測分析市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• IBM
• UnitedHealth Group
• Oracle
• Change Healthcare
• Allscripts Healthcare Solutions
• SAS Institute Inc.
• Wipro Limited
• TIBCO Software
• MedeAnalytics
• Health Catalyst
• Indegene
• Innovaccer
• Qure.ai
• DeepMind Technologies
• Babylon Health
• Insilico Medicine
• BenevolentAI
• Exscientia
• Renalytix AI
• Cloudmed

結論與建議

Global Predictive Disease Analytics Market size was valued at USD 2.6 Billion in 2024 and is poised to grow from USD 3.24 Billion in 2025 to USD 18.96 Billion by 2033, growing at a CAGR of 24.7% during the forecast period (2026-2033).

The global predictive disease analytics market is primarily fueled by the accelerating digitization of health data and advancements in machine learning that convert raw data into actionable insights. This market encompasses software, platforms, and services that integrate clinical, genomic, and social determinant data to anticipate disease onset, progression, and outbreaks, ultimately improving health outcomes and reducing costs. The shift towards value-based care necessitates predictive tools that can identify high-risk patients for efficient resource allocation. Additionally, AI enhances market growth by enabling systems to learn from varied clinical signals, facilitating early detection and personalized risk stratification. Real-world applications range from chronic disease management utilizing wearables to predictive algorithms in hospital settings, creating numerous opportunities for vendors in integrated platforms and outcome-focused contracts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Predictive Disease Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Predictive Disease Analytics Market Segments Analysis

Global predictive disease analytics market is segmented by component, deployment mode, end-user, application area and region. Based on component, the market is segmented into Software and Services. Based on deployment mode, the market is segmented into Cloud-Based and On-Premise. Based on end-user, the market is segmented into Payers, Providers and Others. Based on application area, the market is segmented into Oncology, Cardiovascular Diseases, Infectious Diseases and Personalized Treatment Planning. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Predictive Disease Analytics Market

The global market for predictive disease analytics is significantly driven by advancements in machine learning technologies, which have revolutionized the identification of intricate patterns within a wide array of clinical and epidemiological data. These enhancements lead to improved sensitivity and adaptability of algorithms, facilitating precise risk assessment, prompt identification of outbreak indicators, and customized forecasting for diverse demographics. This progress fosters greater trust among healthcare providers and public health organizations, prompting them to embrace these innovative solutions. As confidence in the efficacy of predictive models rises, it stimulates increased investment in their implementation and integration, thereby fueling market growth and the emergence of new service offerings.

Restraints in the Global Predictive Disease Analytics Market

The Global Predictive Disease Analytics market faces significant constraints due to concerns surrounding data privacy and security, which pose legal and reputational risks that organizations must navigate prior to adoption. These apprehensions lead to prolonged procurement processes and cautious deployment strategies. Compliance with diverse regulatory frameworks and the necessity for robust data governance practices further elevate operational overhead, deterring some institutions from sharing essential datasets. This restriction limits the effectiveness of model training and cross-institutional validation. Consequently, these challenges hinder the integration of predictive analytics into clinical workflows and slow the overall adoption of comprehensive, interoperable solutions within the market.

Market Trends of the Global Predictive Disease Analytics Market

The Global Predictive Disease Analytics market is witnessing a significant shift towards genomics-driven predictive models, driven by advances in genomic interpretation that allow for the integration of heritable risk markers and molecular phenotypes. This innovation empowers personalized risk stratification and prevention strategies, enhancing clinical workflows and multiomic profiles to improve patient management. The demand for explainable outputs and interoperable models fosters greater adoption within health systems, alongside responsible governance practices. Furthermore, strategic partnerships between laboratories, informatics vendors, and healthcare providers streamline the translation of molecular insights into actionable guidance, ultimately promoting sustained population health outcomes across diverse healthcare landscapes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Predictive Disease Analytics Market Size by Component & CAGR (2026-2033)

• Market Overview
• Software
• Services

Global Predictive Disease Analytics Market Size by Deployment Mode & CAGR (2026-2033)

• Market Overview
• Cloud-Based
• On-Premise

Global Predictive Disease Analytics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Payers
• Providers
• Others

Global Predictive Disease Analytics Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiovascular Diseases
• Infectious Diseases
• Personalized Treatment Planning

Global Predictive Disease Analytics Market Size & CAGR (2026-2033)

• North America (Component, Deployment Mode, End-User, Application Area)
  • US
  • Canada
• Europe (Component, Deployment Mode, End-User, Application Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Deployment Mode, End-User, Application Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Deployment Mode, End-User, Application Area)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Deployment Mode, End-User, Application Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IBM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UnitedHealth Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Change Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wipro Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TIBCO Software
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedeAnalytics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indegene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovaccer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qure.ai
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeepMind Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Babylon Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BenevolentAI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exscientia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renalytix AI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cloudmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations